International audiencePseudomonas aeruginosa (PA) is a major public health issue due to its impact on nosocomial infections as well as its impact on cystic fibrosis patient mortality. One of the main concerns is its ability to develop antibiotic resistance. Therefore, inhibition of PA virulence has been proposed as an alternative strategy to tackle PA based infections. LecA (or PA-IL), a galactose binding lectin from PA, is involved in its virulence. Herein, we aimed at designing high affinity synthetic ligands toward LecA for its inhibition and at understanding the key parameters governing the binding of multivalent galactosylated clusters. Twenty-five glycoclusters were synthesized and their bindings were studied on a carbohydrate microar...
Pseudomonas aeruginosa (PA) is a Gram negative opportunistic pathogen and is the major pathogen enco...
Lectin LecA is a virulence factor of Pseudomonas aeruginosa involved in lung injury, mortality, and ...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Pseudomonas aeruginosa (PA) is a major public health issue due to its impact on nosocomial infection...
International audienceAnti‐infectious strategies against pathogen infections can be achieved through...
International audienceAnti‐infectious strategies against pathogen infections can be achieved through...
International audiencePseudomonas aeruginosa (PA) and Burkholderia ambifaria (BA) are two opportunis...
International audienceLectin A (LecA) from Pseudomonas aeruginosa is an established virulence factor...
International audienceDue to the ability of Pseudomonas aeruginosa (PA) to develop antibiotic resist...
The Gram negative bacterium Pseudomonas aeruginosa (PA) is an opportunistic bacterium that causes se...
International audiencePseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two l...
The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic human pathogen asso...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Pseudomonas aeruginosa (PA) is a Gram negative opportunistic pathogen and is the major pathogen enco...
Lectin LecA is a virulence factor of Pseudomonas aeruginosa involved in lung injury, mortality, and ...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Pseudomonas aeruginosa (PA) is a major public health issue due to its impact on nosocomial infection...
International audienceAnti‐infectious strategies against pathogen infections can be achieved through...
International audienceAnti‐infectious strategies against pathogen infections can be achieved through...
International audiencePseudomonas aeruginosa (PA) and Burkholderia ambifaria (BA) are two opportunis...
International audienceLectin A (LecA) from Pseudomonas aeruginosa is an established virulence factor...
International audienceDue to the ability of Pseudomonas aeruginosa (PA) to develop antibiotic resist...
The Gram negative bacterium Pseudomonas aeruginosa (PA) is an opportunistic bacterium that causes se...
International audiencePseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two l...
The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic human pathogen asso...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...
Pseudomonas aeruginosa (PA) is a Gram negative opportunistic pathogen and is the major pathogen enco...
Lectin LecA is a virulence factor of Pseudomonas aeruginosa involved in lung injury, mortality, and ...
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problemati...